Warning: count(): Parameter must be an array or an object that implements Countable in /home/logicben/public_html/drugtrialsformoney.com/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 391

Phase 1b Study to Evaluate ATP128, With or Without BI 754091, in Patients With Stage IV Colorectal Cancer

Phase 1b Study to Evaluate ATP128, With or Without BI 754091, in Patients With Stage IV Colorectal Cancer
Conditions:   Colorectal Cancer;   MSS;   Stage IV Colon Cancer;   Stage IV Rectal Cancer;   Metastatic Colorectal Cancer;   Liver Metastasis Colon Cancer
Interventions:   Drug: ATP128;   Drug: BI 754091
Sponsors:   Amal Therapeutics;   Boehringer Ingelheim
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

August 7, 2019 / by / in
Comments